# Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in Heart Failure With Preserved Ejection Fraction (HFpEF) (INABLE-Training)

> **NCT02713126** · PHASE2 · COMPLETED · sponsor: **Barry Borlaug** · enrollment: 92 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Placebo
- **DRUG:** Sodium Nitrite
- **DEVICE:** Accelerometer
- **OTHER:** Cardiac Exercise Training

## Key facts

- **NCT ID:** NCT02713126
- **Lead sponsor:** Barry Borlaug
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2022-04-12
- **Final completion:** 2022-04-12
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2023-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02713126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02713126, "Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in Heart Failure With Preserved Ejection Fraction (HFpEF) (INABLE-Training)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02713126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*